- Home
- RLAY vs IHS Comparison
RLAY vs IHS Comparison
Compare RLAY & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | IHS |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.8B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RLAY | IHS |
|---|---|---|
| Price | $14.78 | $8.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $19.50 | $8.29 |
| AVG Volume (30 Days) | ★ 4.6M | 1.2M |
| Earning Date | 05-05-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $17.26 |
| Revenue Next Year | $324.03 | $7.87 |
| P/E Ratio | ★ N/A | $5.85 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $2.98 | $5.50 |
| 52 Week High | $17.47 | $8.95 |
Technical Indicators
Market Signals| Indicator | RLAY | IHS |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 58.31 |
| Support Level | $11.68 | $8.14 |
| Resistance Level | $15.45 | $8.41 |
| Average True Range (ATR) | 1.03 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 42.02 | 58.06 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria and Sub-Saharan Africa. The majority of its revenue is derived from Nigeria.